(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PEDI MED

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PEDI MED

ST13

US500000097794426

Class

3

Filing

97794426

Registration

7435026

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

13

Latest update

07/02/2024

Trademark type

Word

Nice classes

3

Filing date

02/14/2023

Registration date

07/02/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/02/2024

Last transaction

07/02/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

First use anywhere

1997-10-00

First use in commerce

1999-11-00

Drawing code

4

Owner type

03

Owner location

Savannah, GA, US

Examiner

ROSSMAN, WILLIAM

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

MW Laboratories Inc.

Representatives

Elizabeth P. West BAY STATE IP, LLC

Technical classification

Nice Classes

Class 3

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

COSMETICSSKIN CARE PRODUCTSNON-MEDICATED FOOT CREAMS AND LOTIONS

Publications

History of USPTO decisions and trademark events.

13 publications found

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/02/2024

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

07/02/2024

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

05/29/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/24/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/24/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/24/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

02/28/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

02/28/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/28/2023

GNRT

NON-FINAL ACTION E-MAILED

11/28/2023

CNRT

NON-FINAL ACTION WRITTEN

11/28/2023

DOCK

ASSIGNED TO EXAMINER

11/13/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/04/2023

Continuous trademark protection

Get notified about every new filing that threatens PEDI MED or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.